Collste Olov, Tornvall Per, Alam Mahbubul, Frick Mats
Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
BMJ Open. 2015 Jul 16;5(7):e007671. doi: 10.1136/bmjopen-2015-007671.
Takotsubo stress cardiomyopathy (TSC) is an increasingly recognised and diagnosed disease, although the underlying pathophysiology is still unknown. Our aim was to investigate the effect of the catecholamine dobutamine on coronary flow reserve (CFR) measured non-invasively in patients with TSC and controls. Our hypothesis was that dobutamine stress can induce microvascular dysfunction in patients with a previous episode of TSC.
This is a case-control study and a substudy of the Stockholm Myocardial Infarction with Normal Coronaries (SMINC) study. Elective dobutamine investigations were performed focusing on non-invasive measurements of CFR. The investigations were performed more than 6 months after the acute event.
22 patients with a previous episode of TSC and 22 sex-matched and age-matched controls were recruited from the SMINC study. All patients with TSC had a previous normal cardiovascular MR investigation.
CFR at low-dose dobutamine was significantly lower in the TSC group compared with controls, 1.51 and 1.72, respectively (p=0.017). At high-dose dobutamine, CFR was 1.95 and 2.21 in the TSC group and controls, respectively (p=0.098).
We could not confirm that the catecholamine dobutamine induced microvascular dysfunction in patients with TSC. However, we found a small but significant difference in CFR at low-dose dobutamine, which implies that the role of microvascular function in TSC needs to be further explored.
应激性心肌病(TSC)是一种日益被认识和诊断的疾病,但其潜在的病理生理学机制仍不清楚。我们的目的是研究儿茶酚胺多巴酚丁胺对TSC患者和对照组无创测量的冠状动脉血流储备(CFR)的影响。我们的假设是,多巴酚丁胺应激可诱发既往有TSC发作史患者的微血管功能障碍。
这是一项病例对照研究,也是斯德哥尔摩正常冠状动脉心肌梗死(SMINC)研究的子研究。进行了选择性多巴酚丁胺研究,重点是CFR的无创测量。研究在急性事件发生6个月后进行。
从SMINC研究中招募了22例既往有TSC发作史的患者和22例性别和年龄匹配的对照组。所有TSC患者既往心血管磁共振检查均正常。
TSC组低剂量多巴酚丁胺时的CFR显著低于对照组,分别为1.51和1.72(p = 0.017)。高剂量多巴酚丁胺时,TSC组和对照组的CFR分别为1.95和2.21(p = 0.098)。
我们不能证实儿茶酚胺多巴酚丁胺会诱发TSC患者的微血管功能障碍。然而,我们发现低剂量多巴酚丁胺时CFR存在微小但显著的差异,这意味着TSC中微血管功能的作用需要进一步探索。